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Background: Tension-type headache and migraine are among the most prevalent chronic disorders in children/
adolescents. Data on health care utilization for headache in this age group, however, are sparse.
Methods: In 1399 grammar school students (aged 12–19 years) with headache in the last six months in Germany
a) the burden of disease for headache (mean intensity, mean frequency in the last three months and PedMIDAS
means), b) medical care utilization defined by proportion of students consulting a physician in the last 12 months
and/or taking analgetic drugs in the last three months by headache types (migraine and tension-type headache)
and by burden of disease were assessed.
Results: Primary headache substantially impaired daily living activities in adolescents which was mainly related
to migraine. Medical care utilization and drug use, however, was low (consulting a physician: 12.0 %, 95 %-CI = [10.3-13.8];
taking analgetic drugs: 29.9 %, 95 %-CI = [27.5-32.4]) - even among students with severe headache (physician consultation:
<35 %; taking analgetic drugs: <63 %). Two thirds of students with any headache and 40 % of those with migraine had
neither seen a physician nor used analgetic drugs because of their headache in the preceding 12 months.
Conclusions: Adolescents with headache might too rarely seek professional help for treatment of headache. Health
promotion in adolescents should increase awareness for evidence-based treatment options for headache.
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Tension-type headache (TTH) and migraine are two of
the most prevalent disorders in the world [1]. Migraine
is the health disorder with the seventh highest impact
on the quality of life and society [2]. Estimates on the
prevalence and burden of disease for headache in chil-
dren and adolescents vary considerably depending on
age, setting, assessment etc. [3]. A recent review cover-
ing 64 headache and migraine studies in children and
adolescents of the past 25 years reported an overall
mean prevalence of 54.4 % for any headache and 9.1 %
for migraine [4]. In the age group of 12 to 15 year old
adolescents another review found a prevalence of 66 to* Correspondence: lucia.albers@med.uni-muenchen.de
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provided the original work is properly credited71% for at least one headache episode in the last three
months, and 33 to 40 % for weekly headaches [5].
The burden of disease for headache in adolescents and
children with respect to the impact on social functioning
and quality of life is difficult to assess. A review on the
impact of headache in children and adolescents stressed
very inconsistent and poorly validated impact measures
in most of the included studies [3]. Two important do-
mains determining the impact of headache are suggested
in this review: 1. Health status of the adolescents in
terms of symptoms and illness control; 2. Functional sta-
tus capturing the ability to perform activities that are es-
sential to meet basic needs, fulfill roles and maintain
well-being. In our study we assessed health status by
headache frequency and pain intensity. The functional
status was measured by the validated PedMIDAS ques-
tionnaire (Pediatric Migraine Disability Assessment
Score) which assesses the impact of headache related toicle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Albers et al. The Journal of Headache and Pain  (2015) 16:52 Page 2 of 7the quality of life in terms of the number of days in the
last three months on which headache had a total or par-
tial impact on schools or home life.
Optimal health care should allow coping with the chal-
lenges of headache with respect to participation in daily
life and quality of life.
In adult populations medical care utilization in terms
of consulting a physician and medication use is well
evaluated [6–11]. For children and adolescents however,
there are currently only very few data available which
often date back at least one decade. There is only one
study from Germany, which is more than nine years old
[12]. From other countries there are two also older stud-
ies on health care utilization in adolescents in the United
States [13,14]. There is only one recent study from Italy
in younger children (aged 3 to 11 years) [15].
The aim of our study is to provide an updated assess-
ment of a) the burden of disease for headache in gram-
mar school students aged 12 to 19 years (both as an
assessment of health status and functional status of the
adolescents), b) medical care utilization of adolescents
with headache in Germany defined by consulting a phys-
ician and/or taking analgetic drugs by headache types
(migraine and TTH) and severity of disease.
Methods
Study population
1674 students of the 8th to 10th grade of 12 grammar
schools in greater Munich (Germany) recruited for a
headache intervention study (reported elsewhere [16])
filled in questionnaires about headache and risk factors
for headache including questions concerning the burden
of disease for headache and use of medical care and
analgetic drugs. 1399 of these students, who reported at
least one headache episode in the last six months, were
included for this analysis.
Assessment of headache, burden of disease, medical care
and use of analgetic drugs
Headache was assessed by the question “Did you experi-
ence headache?”, which could be answered with “yes, in
the last seven days”, “yes in the last three months”, “yes,
in the last six months”, “yes, in the last 12 months” or
“no”. Students, who reported headache in the last seven
days, three or six months were assumed to suffer from
headache. Students, who ticked “yes” were asked further
questions assessing characteristics for classifying the
headache as migraine and TTH (both confirmed and
probable diagnosis) according to the International
Classification of Headache Disorder-III beta (ICHD-III
beta) [17]. A validated pain questionnaire for children
and adolescents was used and specific questions
were added to further classify headache subtypes as mi-
graine or tension-type headache (TTH) according theclassification of the International Headache Society
[18,19]. Individuals with both probable migraine and
probable TTH criteria were given a combined diagnosis
of migraine plus TTH. All subjects with headache that
did not match any of these criteria for primary headache
were considered to have miscellaneous headache
(MiscH).
The burden of disease for headache was assessed by
the following two aspects: 1) Health status of the adoles-
cents measured by the number of headache days in the
last three months and the average pain intensity; pain in-
tensity could be ticked on a Likert scale from 1= “very
mild” to 10= “very severe”. 2) The functional status: dis-
ability due to headache was assessed using PedMIDAS, a
standardized questionnaire consisting of the following
six questions about how much headache is affecting day-
to-day activity in the last three months [20]: (Q1), How
many full days of school were missed in the last
three months due to headaches?”, (Q2) “How many par-
tial days of school were missed in the last three months
due to headaches (do not include full days counted in the
first question)?”, (Q3) “How many days in the last
three months did you function at less than half of your
ability in school because of headache (do not include days
counted in the first two questions)?”, (Q4) “How many
days were you not able to do things at home (i.e., chores,
homework, etc.) due to headache?”, (Q5) “How many days
did you not participate in other activities due to headaches
(i.e., play, go out, sports, etc.)?”, (Q6) “How many days did
you participate in these activities, but functioned at less
than half your ability (do not include days counted in the
5th question)?”. The PedMIDAS total score sums up the
number of days reported in each of the questions. Disabil-
ity grading scores were determined by Hershey et al. based
on the PedMIDAS total score [21] with total scores of 0–
10 as “little to no disability”, 11–30 as “mild disability”,
31–50 as “moderate disability”, and total scores higher
than 50 as “severe disability”. PedMIDAS was shown to
be a sensitive, reliable and valid assessment instru-
ment for headache related disability in children and
adolescents [20].
Usage of analgetic drugs was assessed by the question
“How often in the last three months have you taken
analgetic drugs to treat your headache?” which could be
answered with “never”, “rarely”, “sometimes”, “nearly every
time” or “every time”. Use of analgetic drugs was assumed
if students reported to take at least sometimes analgetic
drugs. Furthermore students were asked if they have seen
a physician because of their headache in the last
12 months, which could be answered with “yes” or “no”.
Statistical analysis
For estimating the burden of disease for headache means
with 95 % confidence intervals (95 %-CIs) were calculated
Table 2 Proportions of students in the PedMIDAS
Disability Grades
PedMIDAS Disability Grades
Little to none Mild Moderate Severe
(0–10) (11–30) (31–50) (>50)
% (N)
Any headache 73.86 19.24 4.99 1.91
N = 1399 (1006) (262) (68) (26)
Headache Types:
Migraine 48.45 31.78 13.18 6.59
N = 262 (125) (82) (34) (17)
TTH 83.33 14.49 2.17 0
N = 138 (115) (20) (3) (0)
Other headache
types N = 999
79.30 16.56 3.21 0.93
(766) (160) (31) (9)
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score, the pain intensity and the number of headache days
in the last three months. To assess the headache type
specific burden for migraine and TTH, means (with 95 %-
CIs) were also given for students with a confirmed diagno-
sis of migraine and TTH (all other students including
those with probable diagnosis of migraine or TTH were
summarized as other headache types).
Group comparisons were made by comparing means
or proportions and the respective binomial 95 %-CIs or
formal chi-square test statistics. A sensitivity analysis
was performed for different definitions of use of analge-
tic drugs: use of any analgetic drugs as compared to at
least sometimes or regular. To assess if patients rather
search sleep instead of taking drugs spearmen test and
correlation coefficient between drug consumption and
seeking sleep for pain relief was calculated.
Results
Table 1 shows some demographic characteristics and the
proportions of headache types in the study population:
there was a slight female predominance; the mean age of
the students was 14.5 years; the proportions of students
in each grade were rather similar; regarding the head-
ache types similar numbers of students with migraine
and TTH were observed, however, confirmed diagnosis
was more common for migraine than for TTH in our
study sample. The mean time period since first onset of
headache was about four years. In total only 17 students
reported to have headache since less than one year.
Based on the disability grades of the PedMIDAS
(Table 2) about 7 % of the students with any headache,
20 % with migraine and only 2 % with TTH were moder-
ately to severely affected by their headache.
The impact of headache on social activities assessed by
the PedMIDAS questions is shown in Table 3: TheTable 1 Demographic characteristics of the study
population
Age (in years) –mean (SD) 14.51 (1.09)
Gender (female) - % (N) 56.94 (796)
Grade - % (N) 8th 32.59 (456)
9th 38.96 (545)
10th 28.45 (398)
Headache types Confirmed migraine 18.73 (262)
Probable migraine 10.86 (152)
Confirmed TTH 9.86 (138)
Probable TTH 19.16 (268)
Migraine + TTH 23.09 (323)
MiscH 18.30 (256)
Time period since the first headache
attack (in years) – mean (SD)
4.18 (3.01)number of total/partial absent days from school and of
school days on which students were considerably re-
stricted in paying attention in class because of their head-
ache was on average 4.4 days in three months for students
with any headache. Pain intensity was on average 5.5
points indicating a moderate pain intensity on average.
The pain intensity differed between migraine and TTH
patients (6.5/10 versus 4.9/10).
The average frequency of headache episodes was about
nine days in the last three months for all students who
had at least one headache episode in the last six months.
A higher number of headache days was observed in mi-
graine. Students suffering from migraine reported on
average about 10 days with severe restrictions in school at-
tendance in the last three months (absent days or >50 %
restricted abilities to attend class). Health care utilization
for headache assessed as seeing a physician in the last
12 months and use of analgetic drugs was low: 12.0 %
(95 %-CI = [10.3-13.8]) of the students with headache have
seen a physician and 29.9 % (95 %-CI = [27.5-32.4]) re-
ported to take analgetic drugs. In migraine patients med-
ical care use was higher: 24.4 % (95 %-CI = [19.3-30.1]) of
migraine patients have seen a physician and 50.8 % (95 %-
CI = [44.5-56.0]) took analgetic drugs.
Students who reported to take analgetic drugs never
or only rarely, did not report to seek sleep more fre-
quently instead – rather the opposite was observed: in-
creasing use of analgetic drugs was positively associated
with an incremental seeking of sleep for headache relief
(r = 0.09, p = 0.0005).
Among the students with headache having seen a
physician 49 % reported using analgetic drugs for man-
agement of acute headache episodes compared to 27 %
of students not having consulted a physician (p < 0.001).
63.8 % of the students with any headache have neither
seen a physician in the last 12 months nor took drugs.
Table 3 Burden of disease in adolescents with headache
PedMIDAS (given as number of days in the last three month) Pain intensity
(1 = “very mild”
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0.57 0.90 3.17 1.81 1.64 1.76 9.33 5.33 8.56
[0.50-0.65] [0.77-1.03] [2.85-3.49] [1.61-2.01] [1.49-1.79] [1.56-1.96] [8.61-10.05] [5.30-5.37] [8.35-8.78]
Headache Types:
Migraine N = 262 1.08 1.82 6.67 4.33 3.46 3.50 19.19 6.51 13.06
[0.88-1.29] [1.35-2.29] [5.46-7.89] [3.49-5.16] [2.93-4.00] [2.70-4.30] [16.45-21.93] [6.44-6.57] [12.38-13.73]
TTH N = 138 0.44 0.66 2.05 1.09 0.98 1.00 5.92 4.94 8.83
[0.25-0.63] [0.42-0.91] [1.61-2.49] [0.78-1.41] [0.64-1.32] [0.75-1.26] [4.78-6.97] [4.85-5.03] [8.27-9.39]
Other headache
types N = 999
0.46 0.69 2.43 1.27 1.26 1.41 7.18 5.08 7.34
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consulted a physician reported to take analgetic drugs
compared to 45.6 % of the students not having seen a
physician (p < 0.005). 41.0 % of the migraine patients
neither have seen a physician nor took analgetic drugs.
Irrespective of how the burden of disease was classified
(PedMIDAS total scale >30, pain intensity >5 or frequency
of more than 6 days of headache in the last three months),
use of health care appeared to be low in general. Even in
the more severe categories health care use did not exceed
60 % (physician consultation: 19 to 35 %; use of analgetic
drugs: 19 to 28 %) (Table 4). As shown in a sensitivity ana-
lysis (Additional file 1: Table S1) defining use of analgetic
drugs as “any use of analgetic drugs” instead of counting
rare use of analgetic drugs as no use shifted these propor-
tions about 20 % higher irrespective of the burden of dis-
ease due to headache observed.
The PedMIDAS scores for students who consulted
and students who did not consult a physician in the last
year is shown in Additional file 2: Figure S1 of the sup-
plemental material: Students who consulted a physician
because of their headaches were more likely to have
“mild”, “moderate” or “severe” than “mild to none” Ped-
MIDAS scores compared to students who did not con-
sult a physician.Table 4 Frequency of medical care utilization by burden of d
Having
headac
Burden of disease %
(N)
[95 %-C










Pain intensity (on Likert
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(125)
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The impact of headache, especially migraine in adoles-
cents was substantial accounting for considerable inabil-
ity to attend school. However, medical care utilization
was low - even among student with severe headache.
Two thirds of students with any headache and 40 % of
those with migraine had neither seen a physician in the
preceding 12 months nor used analgetic drugs in the
preceding three months.
The high burden of disease in children and adolescents
with headache is in line with two previous reviews [3,4].
Three studies cited in these reviews assessed the burden
of migraine by PedMIDAS and reported total scores of
17.8 to 44 days where children/adolescents were totally
or partially disabled at home or at school because of mi-
graine [20–22]. However, these studies were conducted
in a clinical sample which could explain the higher num-
ber of days of impairment in two of these studies. Two
other population based studies reported that students
missed on average 7.2 school days in the last six months
due to migraine, which is comparable to our study
(about 3 days in the last 3 months) [23,24].
For children and adolescents data for headache health
care utilization are sparse. Most studies date back to at
least one decade. There is only one recent study fromisease for headache
seen a physician because of the
he in the last 12 months (yes)
Use of analgetic drugs
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a 9 year old German study (12) use of analgetic drugs
and physician consultation were compared in several
disorders (stomach-, back-, orofacial pain) including
headache (analgetic drugs use <25 %, physician consult-
ation ≤17 %). No differentiation by type of headache is
reported in this study.
A strength of our study and a new aspect is the ana-
lysis of actual data for health care utilization of adoles-
cents with headache in Germany in relation to type and
severity of headache. Furthermore, since the study was
done in an area with general high availability of health
care the low consultation rate seems to reflect the
students’ unawareness of the benefit of medical consult-
ation regarding their headaches rather than lack of treat-
ment facilities. Headache type specific estimates were
confined to categories previously shown to be stable
such as confirmed migraine and TTH [25]. A further
strength of our study is that the burden of disease for
headache was assessed by two domains: The disability
due to headache using an age-adapted, validated and re-
liable instrument (PedMIDAS), and additional the func-
tioning level by considering pain intensity and frequency
of headache of the adolescents [20]. This is important
since the retrospective assessment by PedMIDAS may
be fraught with bias in both directions: 1. Underestima-
tion for non-school days due to headache on weekend
days was shown [26]. 2. Due to the retrospective assess-
ment of the PedMIDAS, recall bias might be possible; it
has been shown, that the recall of the disability due to
headache in the last three months overestimates the
exact number of days compared to a headache diary
[27]. A further limitation could be the failure to assess
distress due to headache and quality of life directly by
including a general quality of life measure (like i.e.
KINDL) in our questionnaire [28]. However, in a former
study in grammar school students in Munich strong re-
striction of the quality of life by headache, especially mi-
graine has been shown [29]. Another measure for the
burden of headache could have been the duration of the
headache episodes, which unfortunately was only
assessed by categories precluding calculation of mean
values for simple assessment of the burden for any head-
ache/headache types. Another weakness of the study
pertains to the failure to ask for prophylactic therapy in
our questionnaire and the specific analgetic drugs which
were used to treat the acute headache attacks. However,
prophylactic medications have to be prescribed by a
physician and the number of patients consulting a phys-
ician was rather low. Thus missed prophylactic drug
treatment is unlikely to be high in our sample.
Ascertainment of physicians’ visits in the last year only
might be an underestimate. Questions about lifetime
consultations because of headache as well as about thecourse of headache (unchanged, improved, deteriorated)
during the previous year as compared to the year before
may have been useful, but unfortunately was not
assessed in our study. Furthermore emergence of head-
ache might have been too recent to allow for a doctor’s
visit. As only 17 students reported to have headache
since less than one year, however, it seems very unlikely
that students did not consult a doctor in the last year
because the time since onset of headache was too short
for making an appointment.
A further source of bias could be problems in under-
standing the difference between analgetic drugs and pre-
scription medication in the students. However, analgetic
drug in German means any drug used for pain relief ir-
respective of whether the drug is prescribed or OTC and
therefore this seems rather unlikely.
Limited external validity is a weakness of this paper
since the study was performed in grammar school stu-
dents in an urban environment. However, since grammar
school students usually have a higher socioeconomic fam-
ily background, it is likely that access to health care in less
privileged children with headache is even lower.Conclusion
Adolescents in Germany with primary headaches, specif-
ically migraine, have a high burden of disease. Although
health care utilization is higher in migraineurs (particu-
larly among those more severely affected) than for other
types of headache, almost 40 % of the students with mi-
graine had neither seen a physician during the previous
12 months nor reported medical treatment. Health care
promotion in adolescents should include elements to in-
crease awareness for treatment options for headache.Additional files
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